10 Vertex Pharmaceuticals regulatory affairs leaders
Chief Regulatory Officer at Vertex Pharmaceuticals, Sr Director Regulatory Affairs (CMC) and Director, Regulatory Affairs Labeling are among the current titles held by these Vertex Pharmaceuticals regulatory affairs leaders. A reader can learn how regulatory affairs leaders work at Vertex Pharmaceuticals from people who have held the role.
Professionals to explore
Alka Saxena
LinkedInExperience: Director of Regulatory Affairs · Vertex Pharmaceuticals
Alka Saxena has been Director of Regulatory Affairs at Vertex Pharmaceuticals since November 2025, based in Kensington, Maryland. At Takeda, Alka Saxena was Director Global Regulatory Affairs from 2024 to 2025 and Associate Director Regulatory Affairs from 2022 to 2024, and Alka Saxena was Senior Manager Regulatory Affairs at Seagen from 2019 to 2022.
Angela Pontrello, M.S., MBA
LinkedInExperience: Sr Director Regulatory Affairs (CMC) · Vertex Pharmaceuticals
Angela Pontrello has been Sr Director Regulatory Affairs (CMC) at Vertex Pharmaceuticals since August 2024 and was Director Regulatory Affairs CMC there from 2022 to 2024, based in Waltham, Massachusetts. At Blueprint Medicines, Angela Pontrello was Director Global Regulatory Sciences (CMC) from 2020 to 2022 and Director Quality Control from 2018 to 2020.
Carrie Mazzrillo, BS, MBA, PMP
LinkedInExperience: Director, Regulatory Submission Management, Global Regulatory Operations · Vertex Pharmaceuticals
Carrie Mazzrillo has been Director, Regulatory Submission Management, Global Regulatory Operations at Vertex Pharmaceuticals since August 2021, based in Framingham, Massachusetts. Carrie Mazzrillo was Associate Director, Regulatory Submission Management, Global Regulatory Operations at Vertex Pharmaceuticals from 2018 to 2021 and Senior Submission Manager, Global Regulatory Operations at Eisai US from 2015 to 2018.
Cassidy Kelley
LinkedInExperience: Director, Regulatory Strategy · Vertex Pharmaceuticals
Cassidy Kelley has been Director, Regulatory Strategy at Vertex Pharmaceuticals since August 2026, and the profile headline reads Global Regulatory Lead. At Vertex Pharmaceuticals, Cassidy Kelley was Associate Director, Regulatory Strategy from 2025 to 2026 and Senior Manager, Regulatory Strategy from 2022 to 2025, and was Regulatory Manager at Imara Inc. from 2021 to 2022.
Christin Lydon
LinkedInExperience: Director, Regulatory Affairs, Advertising and Promotion · Vertex Pharmaceuticals
Christin Lydon has been Director, Regulatory Affairs, Advertising and Promotion at Vertex Pharmaceuticals since June 2022 and was Associate Director, Regulatory Affairs, Advertising and Promotion there from 2020 to 2022, based in Boston, Massachusetts. Christin Lydon was Associate Director, Regulatory Affairs, Promotion and Labeling at EMD Serono, Inc. from 2018 to 2020.
Dani Sweeney MS, RAC
LinkedInExperience: Director Global Regulatory Lead · Vertex Pharmaceuticals
Dani Sweeney has been Director Global Regulatory Lead at Vertex Pharmaceuticals since January 2025, based in Boston, Massachusetts. At Takeda, Dani Sweeney was Associate Director, Global Regulatory Lead from 2022 to 2025 and Senior Manager, US International Regulatory Strategist from 2020 to 2022, and was Regulatory Affairs Manager at AVROBIO from 2019 to 2020.
Karla Cuevas
LinkedInExperience: Director, Regulatory Affairs Labeling · Vertex Pharmaceuticals
Karla Cuevas has been Director, Regulatory Affairs Labeling at Vertex Pharmaceuticals since January 2023, based in the New York City Metropolitan Area. Karla Cuevas was Clinical Program Lead, Medical Device and Combination Products at Takeda from 2019 to 2022, Associate Director, Regulatory Labeling Strategy at Takeda from 2018 to 2019 and Manager, Regulatory Labeling Lead at Shire from 2015 to 2018.
Kristen Clare
LinkedInExperience: Director Global Regulatory Affairs · Vertex Pharmaceuticals
Kristen Clare has been Director Global Regulatory Affairs at Vertex Pharmaceuticals since September 2023, based in Greater Boston. Kristen Clare was Director, Regulatory Affairs at Alkermes from 2020 to 2023 and Associate Director, Global Regulatory Lead at Takeda from 2018 to 2020, and held the title Manager, US Regulatory Strategist (Shire) at Takeda from 2015 to 2017.
Nia Tatsis
LinkedInExperience: Chief Regulatory Officer · Vertex Pharmaceuticals
Nia Tatsis has held the title Chief Regulatory Officer at Vertex Pharmaceuticals since October 2019, and the profile headline reads EVP, Chief Regulatory and Quality Officer at Vertex Pharmaceuticals. Nia Tatsis was Senior Vice President Global Regulatory Affairs at Vertex Pharmaceuticals from 2017 to 2019 and VP Global Regulatory Head Sanofi Genzyme BU at Sanofi from 2014 to 2019.
Ping Yin
LinkedInExperience: Regulatory Affairs CMC Director · Vertex Pharmaceuticals
Ping Yin has been Regulatory Affairs CMC Director at Vertex Pharmaceuticals since January 2025, based in Boston, Massachusetts. At Vertex Pharmaceuticals, Ping Yin was Regulatory Affairs CMC Associate Director from 2023 to 2025, Regulatory Affairs CMC Sr. Manager from 2021 to 2023 and Regulatory Affairs CMC Manager from 2018 to 2021.
Choose the right perspective
Match the scope in a person's title, such as global regulatory strategy, regulatory CMC, labeling or regulatory operations, to the question you need answered. Weigh how recently each person held the role and whether a director-level or executive-level view fits your question better.
Questions to take into the conversation
- 01What did you focus on first when you took on your regulatory affairs role at Vertex Pharmaceuticals?
- 02What has changed in how you approach regulatory work since you took on your current role?
- 03What has your own work at Vertex Pharmaceuticals taught you about building a regulatory affairs team?
Reaching Vertex Pharmaceuticals regulatory affairs leaders
How can I contact one of these Vertex Pharmaceuticals regulatory affairs leaders?
Pick one of the 10 people on this page and choose "Book a paid call", or describe your project to find others. You offer a fee for a 15-minute call or a written answer, Instant Expert finds the person's work email and sends the invitation, and they decide whether to accept. The list covers 1 company: Vertex Pharmaceuticals, based on profile data retrieved on October 24, 2026. Being listed here doesn't mean someone has agreed to take calls.
How much does it cost to reach Vertex Pharmaceuticals regulatory affairs leaders?
You choose the offer, starting at $5 per person. The offer is what the person receives, and Instant Expert's fee is added on top, so a $100 offer costs you $125. The fee is 20% of what you pay. You're charged only when the person books the call or sends the answer.
What if they don't reply?
You pay nothing. Instant Expert sends follow-up reminders, and if the person hasn't booked or answered within 7 days, the request expires and any hold on your card is released. You can invite several of the 10 people on this list at once and cap your total spend, so you pay only for the ones who accept.
Can an AI agent ask one of these Vertex Pharmaceuticals regulatory affairs leaders a question?
Yes. An agent with a USDC wallet on Base can ask one question without an Instant Expert account. It names the person, for example by the LinkedIn URL on this page, and pays per ask over x402 (HTTP 402). The person answers in writing or by voice note, and if nobody answers within 7 days, the payment goes back to the wallet automatically. Claude and ChatGPT can do the same through the Instant Expert connector: setup is at /docs/mcp for Claude and /docs/chatgpt for ChatGPT. x402 docs
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.
Request a correction or removal